$140.5
Currently 42 wall-street analysts regularly analyze the financials of Biogen Inc. on a frequent basis to provide recommendations along with target share price. 42 analysts offering 12-month price forecasts for Biogen Inc. (BIIB) have a share price target of $201.18. This median of share price forecast represents a 43.19% upside from the latest price of $140.5 as on 06.03.25.
As per the chart shown above, analysts believe that the Biogen Inc. (BIIB) share price will touch around $201.18 in next 12-months.
Below is a chart showing the percentage difference between Biogen Inc.'s share price and its median forecast price. As on 06.03.25, the difference is -30.95%
Based on 42 analysts tracking and researching Biogen Inc. (BIIB) share have buy recommendation on an average.
3M Ago | 1M Ago | Current | |
Buy | 22 | 20 | 20 |
Outperform | 10 | 10 | 10 |
Hold | 10 | 12 | 12 |
Underperform | 0 | 0 | 0 |
Sell | 0 | 0 | 0 |